Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

101 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
[Role of local treatments in prostate cancer].
Ohlmann CH, Grimm MO. Ohlmann CH, et al. Urologie. 2024 Mar;63(3):213-214. doi: 10.1007/s00120-024-02286-7. Epub 2024 Mar 6. Urologie. 2024. PMID: 38446156 German. No abstract available.
Correction to: LHRH sparing therapy in patients with chemotherapy-naïve, mCRPC treated with abiraterone acetate plus prednisone: results of the randomized phase II SPARE trial.
Ohlmann CH, Jäschke M, Jaehnig P, Krege S, Gschwend J, Rexer H, Junker K, Zillmann R, Rüssel C, Hellmis E, Suttmann H, Janssen M, Marin J, Hübner A, Mathers M, Gleißner J, Scheffler M, Feyerabend S, Telle J, Klier J, Stöckle M. Ohlmann CH, et al. Prostate Cancer Prostatic Dis. 2023 Dec;26(4):812. doi: 10.1038/s41391-023-00682-2. Prostate Cancer Prostatic Dis. 2023. PMID: 37253975 Free PMC article. No abstract available.
DEPROMP Trial: the additive value of PSMA-PET/CT-guided biopsy for prostate cancer management in biopsy naïve men-study protocol for a randomized trial.
Krausewitz P, Bundschuh RA, Gaertner FC, Essler M, Attenberger U, Luetkens J, Kristiansen G, Muders M, Ohlmann CH, Hauser S, Ellinger J, Ritter M. Krausewitz P, et al. Among authors: ohlmann ch. Trials. 2023 Mar 6;24(1):167. doi: 10.1186/s13063-023-07197-0. Trials. 2023. PMID: 36879271 Free PMC article.
[Quality assurance for the treatment of muscle-invasive and metastasized bladder carcinoma in Germany : An initiative of the Working Groups Urological Oncology (AUO) and Internal Oncology (AIO) in the German Cancer Society (DKG)].
Ohlmann CH, Kerkmann M, Holtmann L, Gschwend JE, Retz M, de Wit M. Ohlmann CH, et al. Urologie. 2022 Dec;61(12):1351-1364. doi: 10.1007/s00120-022-01870-z. Epub 2022 Jun 29. Urologie. 2022. PMID: 35925102 Free PMC article. German.
LHRH sparing therapy in patients with chemotherapy-naïve, mCRPC treated with abiraterone acetate plus prednisone: results of the randomized phase II SPARE trial.
Ohlmann CH, Jäschke M, Jaehnig P, Krege S, Gschwend J, Rexer H, Junker K, Zillmann R, Rüssel C, Hellmis E, Suttmann H, Janssen M, Marin J, Hübner A, Mathers M, Gleißner J, Scheffler M, Feyerabend S, Telle J, Klier J, Stöckle M. Ohlmann CH, et al. Prostate Cancer Prostatic Dis. 2022 Apr;25(4):778-784. doi: 10.1038/s41391-022-00533-6. Epub 2022 Apr 16. Prostate Cancer Prostatic Dis. 2022. PMID: 35430584 Free PMC article. Clinical Trial.
101 results